ARMONAIR DIGIHALER Drug Patent Profile
✉ Email this page to a colleague
When do Armonair Digihaler patents expire, and when can generic versions of Armonair Digihaler launch?
Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. There are twenty-five patents protecting this drug.
This drug has four hundred and forty-nine patent family members in thirty-four countries.
The generic ingredient in ARMONAIR DIGIHALER is fluticasone propionate. There are twenty-nine drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Armonair Digihaler
A generic version of ARMONAIR DIGIHALER was approved as fluticasone propionate by FOUGERA PHARMS on May 14th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ARMONAIR DIGIHALER?
- What are the global sales for ARMONAIR DIGIHALER?
- What is Average Wholesale Price for ARMONAIR DIGIHALER?
Summary for ARMONAIR DIGIHALER
International Patents: | 449 |
US Patents: | 25 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 86 |
Patent Applications: | 5,455 |
Drug Prices: | Drug price information for ARMONAIR DIGIHALER |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ARMONAIR DIGIHALER |
What excipients (inactive ingredients) are in ARMONAIR DIGIHALER? | ARMONAIR DIGIHALER excipients list |
DailyMed Link: | ARMONAIR DIGIHALER at DailyMed |


Pharmacology for ARMONAIR DIGIHALER
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for ARMONAIR DIGIHALER
ARMONAIR DIGIHALER is protected by twenty-six US patents and two FDA Regulatory Exclusivities.
Expired US Patents for ARMONAIR DIGIHALER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-004 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-004 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-005 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-006 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-005 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-006 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ARMONAIR DIGIHALER
See the table below for patents covering ARMONAIR DIGIHALER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Peru | 20020163 | SISTEMA PRESURIZADO DE RECEPTACULO PARA INHALADOR DE MEDICAMENTO | ⤷ Try for Free |
South Korea | 20190087475 | 전자 장치를 구비한 약물 전달 기구 | ⤷ Try for Free |
Denmark | 1294421 | ⤷ Try for Free | |
Israel | 223116 | מוני מינון למשאפים, משאפים ועמודים למשאפים (Dose counters for inhalers, inhalers and shafts thereof) | ⤷ Try for Free |
Japan | 4897570 | ⤷ Try for Free | |
Australia | 2020200884 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ARMONAIR DIGIHALER
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2506844 | SPC/GB18/020 | United Kingdom | ⤷ Try for Free | PRODUCT NAME: A PHARMACEUTICAL COMBINATION PRODUCT COMPRISING A PHARMACEUTICALLY ACCEPTABLE SALT OF UMECLIDINIUM (E.G. UMECLIDINIUM BROMIDE), VILANTEROL OR A PHARMACEUTICALLY ACCETPABLE SALT THEREOF (E.G. VILANTEROL TRIFENATATE), AND FLUTICASONE FUROATE; REGISTERED: UK EU/1/17/1236/001(NI) 20171117; UK EU/1/17/1236/002(NI) 20171117; UK EU/1/17/1236/003(NI) 20171117; UK PLGB 19494/0287 20171117 |
2506844 | 18C1022 | France | ⤷ Try for Free | PRODUCT NAME: COMBINAISON COMPRENANT UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'UMECLIDINIUM (EN PARTICULIER LE BROMURE D'UMECLIDINIUM), DU VILANTEROL OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (EN PARTICULIER LE TRIFENATATE DE VILANTEROL), ET DU FUROATE DE FLUTICASONE; REGISTRATION NO/DATE: EU/1/17/1236 20171117 |
2506844 | 132018000000341 | Italy | ⤷ Try for Free | PRODUCT NAME: UN PRODOTTO DI COMBINAZIONE FARMACEUTICA COMPRENDENTE UN SALE FARMACEUTICAMENTE ACCETTABILE DI UMECLIDINIO (AD ESEMPIO BROMURO DI UMECLIDINIO), VILANTEROLO O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE (AD ESEMPIO VILANTEROLO TRIFENATATO) E UN FUROATO(TRELEGY ELLIPTA - FLUTICASONE FUROATO/UMECLIDINIO/VILANTEROLO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1236, 20171117 |
1519731 | 92269 | Luxembourg | ⤷ Try for Free | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
1305329 | 08C0014 | France | ⤷ Try for Free | PRODUCT NAME: FLUTICASONE FUROATE; REGISTRATION NO/DATE: EU/1/07/434/001 20080111 |
2506844 | 1890025-8 | Sweden | ⤷ Try for Free | PRODUCT NAME: COMBINATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF UMECLIDINIUM (E.G. UMECLIDINIUM BROMIDE), VILANTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEROF (E.G. VILANTEROL TRIFENATATE) AND FLUTICASONE FUROATE.; REG. NO/DATE: EU/1/17/1236 20171117 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for ArmonAir Digihaler
More… ↓